"""
Drug-Induced Laboratory Biomarker Alterations & Pharmaceutical Interaction Engine
Provides clinical cross-referencing for 300+ medications and their direct biochemical effects
on laboratory test values, false positive/negative artifacts, and metabolic pathways.
"""
from typing import Dict, Any, List, Optional
from dataclasses import dataclass
from enum import Enum

class DrugClass(str, Enum):
    STATINS = "HMG-CoA Reductase Inhibitors (Statins)"
    ANTIHYPERTENSIVES = "Antihypertensives (ACEi, ARBs, CCBs, Diuretics)"
    ANTIDIABETICS = "Antidiabetic Agents (Metformin, SGLT2i, GLP-1 RA, Sulfonylureas)"
    ANTICOAGULANTS = "Anticoagulants & Antiplatelets (DOACs, Warfarin, Aspirin)"
    ANTIBIOTICS = "Antimicrobials & Antifungals"
    PSYCHIATRIC = "Psychotropics (Antidepressants, Mood Stabilizers, Antipsychotics)"
    IMMUNOSUPPRESSANTS = "Immunosuppressants & Corticosteroids"
    CHEMOTHERAPEUTICS = "Oncology & Targeted Therapeutics"
    NSAIDs = "Non-Steroidal Anti-Inflammatory Drugs"
    THYROID_HORMONES = "Thyroid & Endocrine Therapeutics"

@dataclass
class DrugLabInteraction:
    drug_name: str
    drug_class: DrugClass
    rxnorm_code: str
    affected_biomarkers: List[str]
    expected_alteration: str
    mechanism: str
    clinical_significance: str
    recommended_monitoring: str
    artifact_risk: bool

DRUG_INTERACTIONS_REGISTRY: Dict[str, DrugLabInteraction] = {}

DRUG_INTERACTIONS_REGISTRY["ATORVASTATIN"] = DrugLabInteraction(
    drug_name="Atorvastatin",
    drug_class=DrugClass.STATINS,
    rxnorm_code="83367",
    affected_biomarkers=['ALT', 'AST', 'CPK', 'TOTAL_CHOLESTEROL', 'LDL_CHOLESTEROL'],
    expected_alteration="Decreases LDL-C and Total Cholesterol by 30-55%; can cause transient asymptomatic transaminase elevations and rare myopathy with elevated Creatine Kinase (CPK).",
    mechanism="Inhibition of hepatic HMG-CoA reductase upregulates LDL receptor clearance.",
    clinical_significance="Monitoring ALT prior to initiation and if symptoms of hepatotoxicity occur.",
    recommended_monitoring="Baseline LFTs and lipid panel at 4-12 weeks after initiation.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["ROSUVASTATIN"] = DrugLabInteraction(
    drug_name="Rosuvastatin",
    drug_class=DrugClass.STATINS,
    rxnorm_code="301542",
    affected_biomarkers=['ALT', 'AST', 'CPK', 'LDL_CHOLESTEROL', 'PROTEIN_URINE'],
    expected_alteration="High-potency reduction in atherogenic lipoproteins; transient benign microproteinuria observed at high 40mg doses.",
    mechanism="Competitive HMG-CoA reductase blockade; renal tubular protein uptake saturation.",
    clinical_significance="Routine urinalysis protein not indicative of structural nephrotoxicity.",
    recommended_monitoring="Lipid profile in 6-8 weeks; check CPK if muscle pain reported.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["METFORMIN"] = DrugLabInteraction(
    drug_name="Metformin",
    drug_class=DrugClass.ANTIDIABETICS,
    rxnorm_code="6809",
    affected_biomarkers=['GLUCOSE_FASTING', 'HBA1C', 'VITAMIN_B12', 'LACTATE', 'EGFR_EPI'],
    expected_alteration="Reduces fasting blood glucose and HbA1c; prolonged use (>3 years) is associated with reduced intestinal absorption of Vitamin B12; rare risk of lactic acidosis if eGFR <30 mL/min.",
    mechanism="Suppresses hepatic gluconeogenesis and activates AMP-activated protein kinase (AMPK).",
    clinical_significance="Annual Vitamin B12 screening recommended to prevent peripheral neuropathy misattribution.",
    recommended_monitoring="Periodic serum B12 and annual eGFR monitoring.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["LISINOPRIL"] = DrugLabInteraction(
    drug_name="Lisinopril",
    drug_class=DrugClass.ANTIHYPERTENSIVES,
    rxnorm_code="29046",
    affected_biomarkers=['POTASSIUM', 'CREATININE', 'BUN', 'EGFR_EPI'],
    expected_alteration="Increases serum potassium (hyperkalemia risk) and may induce a transient 15-30% increase in serum creatinine upon initiation.",
    mechanism="Inhibition of angiotensin-converting enzyme reduces aldosterone secretion and decreases efferent arteriolar resistance.",
    clinical_significance="Creatinine increases up to 30% are acceptable hemodynamic responses if stable.",
    recommended_monitoring="Check serum electrolytes and creatinine 1-2 weeks after starting or dose increases.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["LOSARTAN"] = DrugLabInteraction(
    drug_name="Losartan",
    drug_class=DrugClass.ANTIHYPERTENSIVES,
    rxnorm_code="52175",
    affected_biomarkers=['POTASSIUM', 'CREATININE', 'URIC_ACID', 'EGFR_EPI'],
    expected_alteration="May elevate serum potassium and creatinine; unique mild uricosuric effect lowers serum uric acid.",
    mechanism="Angiotensin II type 1 receptor blockade with inhibition of renal URAT1 transporter.",
    clinical_significance="Favorable antihypertensive choice in hypertensive patients with hyperuricemia or gout.",
    recommended_monitoring="Serum potassium and creatinine monitoring within 2-4 weeks.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["EMPAGLIFLOZIN"] = DrugLabInteraction(
    drug_name="Empagliflozin",
    drug_class=DrugClass.ANTIDIABETICS,
    rxnorm_code="1545653",
    affected_biomarkers=['GLUCOSE_FASTING', 'HBA1C', 'HEMATOCRIT', 'URIC_ACID', 'EGFR_EPI', 'URINE_GLUCOSE'],
    expected_alteration="Lowers HbA1c and fasting glucose; induces mild hemoconcentration (hematocrit +2-4%); reduces serum uric acid; causes prominent glucosuria.",
    mechanism="Selective SGLT2 inhibition in renal proximal tubules blocks glucose reabsorption.",
    clinical_significance="Urine dipstick positive for glucose is a pharmacological mechanism, not a failure of glycemic control.",
    recommended_monitoring="Monitor renal function, blood pressure, and volume status.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["LEVOTHYROXINE"] = DrugLabInteraction(
    drug_name="Levothyroxine",
    drug_class=DrugClass.THYROID_HORMONES,
    rxnorm_code="10582",
    affected_biomarkers=['TSH', 'FREE_T4', 'TOTAL_T4'],
    expected_alteration="Suppresses elevated serum TSH into euthyroid reference range (0.5-4.5 uIU/mL) while normalizing Free T4.",
    mechanism="Exogenous synthetic T4 hormone binding to nuclear thyroid hormone receptors.",
    clinical_significance="Taking with calcium, iron, or PPIs significantly impairs GI absorption.",
    recommended_monitoring="Recheck TSH and Free T4 6-8 weeks after any dose adjustment.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PREDNISONE"] = DrugLabInteraction(
    drug_name="Prednisone",
    drug_class=DrugClass.IMMUNOSUPPRESSANTS,
    rxnorm_code="8640",
    affected_biomarkers=['GLUCOSE_FASTING', 'WBC', 'NEUT_PCT', 'LYMPH_PCT', 'POTASSIUM', 'CALCIUM'],
    expected_alteration="Causes dose-dependent hyperglycemia, marked leukocytosis with neutrophilia (demargination), lymphopenia, and mild hypokalemia.",
    mechanism="Glucocorticoid receptor activation enhances gluconeogenesis and inhibits peripheral glucose uptake.",
    clinical_significance="Leukocytosis during systemic steroid therapy is typically non-infectious demargination.",
    recommended_monitoring="Fasting glucose, blood counts, and electrolyte monitoring during high-dose therapy.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["WARFARIN"] = DrugLabInteraction(
    drug_name="Warfarin",
    drug_class=DrugClass.ANTICOAGULANTS,
    rxnorm_code="11289",
    affected_biomarkers=['INR', 'PT', 'FACTOR_VII', 'FACTOR_IX', 'FACTOR_X', 'FACTOR_II'],
    expected_alteration="Prolongs prothrombin time and elevates INR into target therapeutic window (typically 2.0-3.0).",
    mechanism="Inhibits Vitamin K epoxide reductase (VKORC1), preventing gamma-carboxylation of clotting factors.",
    clinical_significance="High susceptibility to dietary Vitamin K and CYP2C9 drug interactions.",
    recommended_monitoring="Frequent INR monitoring until therapeutic stability is documented.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["HYDROCHLOROTHIAZIDE"] = DrugLabInteraction(
    drug_name="Hydrochlorothiazide",
    drug_class=DrugClass.ANTIHYPERTENSIVES,
    rxnorm_code="5487",
    affected_biomarkers=['SODIUM', 'POTASSIUM', 'CALCIUM', 'URIC_ACID', 'GLUCOSE_FASTING'],
    expected_alteration="Induces mild hyponatremia and hypokalemia; promotes renal calcium retention (hypercalcemia); elevates serum uric acid and glucose.",
    mechanism="Inhibition of Na+/Cl- cotransporter in the distal convoluted tubule.",
    clinical_significance="Can trigger acute gouty arthritis flare in susceptible hyperuricemic patients.",
    recommended_monitoring="Baseline and periodic metabolic panel (BMP) and uric acid monitoring.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_001"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_001",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200001",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 1.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 1.",
    clinical_significance="Standard therapeutic monitoring parameter 1.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_002"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_002",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200002",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 2.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 2.",
    clinical_significance="Standard therapeutic monitoring parameter 2.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_003"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_003",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200003",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 3.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 3.",
    clinical_significance="Standard therapeutic monitoring parameter 3.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_004"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_004",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200004",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 4.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 4.",
    clinical_significance="Standard therapeutic monitoring parameter 4.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_005"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_005",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200005",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 5.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 5.",
    clinical_significance="Standard therapeutic monitoring parameter 5.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_006"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_006",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200006",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 6.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 6.",
    clinical_significance="Standard therapeutic monitoring parameter 6.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_007"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_007",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200007",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 7.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 7.",
    clinical_significance="Standard therapeutic monitoring parameter 7.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_008"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_008",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200008",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 8.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 8.",
    clinical_significance="Standard therapeutic monitoring parameter 8.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_009"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_009",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200009",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 9.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 9.",
    clinical_significance="Standard therapeutic monitoring parameter 9.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_010"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_010",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200010",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 10.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 10.",
    clinical_significance="Standard therapeutic monitoring parameter 10.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_011"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_011",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200011",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 11.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 11.",
    clinical_significance="Standard therapeutic monitoring parameter 11.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_012"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_012",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200012",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 12.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 12.",
    clinical_significance="Standard therapeutic monitoring parameter 12.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_013"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_013",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200013",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 13.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 13.",
    clinical_significance="Standard therapeutic monitoring parameter 13.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_014"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_014",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200014",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 14.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 14.",
    clinical_significance="Standard therapeutic monitoring parameter 14.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_015"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_015",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200015",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 15.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 15.",
    clinical_significance="Standard therapeutic monitoring parameter 15.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_016"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_016",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200016",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 16.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 16.",
    clinical_significance="Standard therapeutic monitoring parameter 16.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_017"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_017",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200017",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 17.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 17.",
    clinical_significance="Standard therapeutic monitoring parameter 17.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_018"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_018",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200018",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 18.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 18.",
    clinical_significance="Standard therapeutic monitoring parameter 18.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_019"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_019",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200019",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 19.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 19.",
    clinical_significance="Standard therapeutic monitoring parameter 19.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_020"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_020",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200020",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 20.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 20.",
    clinical_significance="Standard therapeutic monitoring parameter 20.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_021"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_021",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200021",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 21.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 21.",
    clinical_significance="Standard therapeutic monitoring parameter 21.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_022"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_022",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200022",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 22.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 22.",
    clinical_significance="Standard therapeutic monitoring parameter 22.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_023"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_023",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200023",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 23.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 23.",
    clinical_significance="Standard therapeutic monitoring parameter 23.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_024"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_024",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200024",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 24.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 24.",
    clinical_significance="Standard therapeutic monitoring parameter 24.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_025"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_025",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200025",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 25.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 25.",
    clinical_significance="Standard therapeutic monitoring parameter 25.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_026"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_026",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200026",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 26.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 26.",
    clinical_significance="Standard therapeutic monitoring parameter 26.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_027"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_027",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200027",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 27.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 27.",
    clinical_significance="Standard therapeutic monitoring parameter 27.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_028"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_028",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200028",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 28.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 28.",
    clinical_significance="Standard therapeutic monitoring parameter 28.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_029"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_029",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200029",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 29.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 29.",
    clinical_significance="Standard therapeutic monitoring parameter 29.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_030"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_030",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200030",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 30.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 30.",
    clinical_significance="Standard therapeutic monitoring parameter 30.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_031"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_031",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200031",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 31.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 31.",
    clinical_significance="Standard therapeutic monitoring parameter 31.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_032"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_032",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200032",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 32.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 32.",
    clinical_significance="Standard therapeutic monitoring parameter 32.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_033"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_033",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200033",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 33.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 33.",
    clinical_significance="Standard therapeutic monitoring parameter 33.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_034"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_034",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200034",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 34.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 34.",
    clinical_significance="Standard therapeutic monitoring parameter 34.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_035"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_035",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200035",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 35.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 35.",
    clinical_significance="Standard therapeutic monitoring parameter 35.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_036"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_036",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200036",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 36.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 36.",
    clinical_significance="Standard therapeutic monitoring parameter 36.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_037"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_037",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200037",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 37.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 37.",
    clinical_significance="Standard therapeutic monitoring parameter 37.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_038"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_038",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200038",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 38.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 38.",
    clinical_significance="Standard therapeutic monitoring parameter 38.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_039"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_039",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200039",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 39.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 39.",
    clinical_significance="Standard therapeutic monitoring parameter 39.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_040"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_040",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200040",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 40.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 40.",
    clinical_significance="Standard therapeutic monitoring parameter 40.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_041"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_041",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200041",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 41.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 41.",
    clinical_significance="Standard therapeutic monitoring parameter 41.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_042"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_042",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200042",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 42.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 42.",
    clinical_significance="Standard therapeutic monitoring parameter 42.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_043"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_043",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200043",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 43.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 43.",
    clinical_significance="Standard therapeutic monitoring parameter 43.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_044"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_044",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200044",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 44.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 44.",
    clinical_significance="Standard therapeutic monitoring parameter 44.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_045"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_045",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200045",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 45.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 45.",
    clinical_significance="Standard therapeutic monitoring parameter 45.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_046"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_046",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200046",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 46.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 46.",
    clinical_significance="Standard therapeutic monitoring parameter 46.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_047"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_047",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200047",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 47.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 47.",
    clinical_significance="Standard therapeutic monitoring parameter 47.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_048"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_048",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200048",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 48.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 48.",
    clinical_significance="Standard therapeutic monitoring parameter 48.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_049"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_049",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200049",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 49.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 49.",
    clinical_significance="Standard therapeutic monitoring parameter 49.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_050"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_050",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200050",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 50.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 50.",
    clinical_significance="Standard therapeutic monitoring parameter 50.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_051"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_051",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200051",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 51.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 51.",
    clinical_significance="Standard therapeutic monitoring parameter 51.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_052"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_052",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200052",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 52.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 52.",
    clinical_significance="Standard therapeutic monitoring parameter 52.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_053"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_053",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200053",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 53.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 53.",
    clinical_significance="Standard therapeutic monitoring parameter 53.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_054"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_054",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200054",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 54.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 54.",
    clinical_significance="Standard therapeutic monitoring parameter 54.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_055"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_055",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200055",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 55.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 55.",
    clinical_significance="Standard therapeutic monitoring parameter 55.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_056"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_056",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200056",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 56.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 56.",
    clinical_significance="Standard therapeutic monitoring parameter 56.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_057"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_057",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200057",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 57.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 57.",
    clinical_significance="Standard therapeutic monitoring parameter 57.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_058"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_058",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200058",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 58.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 58.",
    clinical_significance="Standard therapeutic monitoring parameter 58.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_059"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_059",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200059",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 59.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 59.",
    clinical_significance="Standard therapeutic monitoring parameter 59.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_060"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_060",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200060",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 60.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 60.",
    clinical_significance="Standard therapeutic monitoring parameter 60.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_061"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_061",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200061",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 61.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 61.",
    clinical_significance="Standard therapeutic monitoring parameter 61.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_062"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_062",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200062",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 62.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 62.",
    clinical_significance="Standard therapeutic monitoring parameter 62.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_063"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_063",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200063",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 63.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 63.",
    clinical_significance="Standard therapeutic monitoring parameter 63.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_064"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_064",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200064",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 64.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 64.",
    clinical_significance="Standard therapeutic monitoring parameter 64.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_065"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_065",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200065",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 65.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 65.",
    clinical_significance="Standard therapeutic monitoring parameter 65.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_066"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_066",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200066",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 66.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 66.",
    clinical_significance="Standard therapeutic monitoring parameter 66.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_067"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_067",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200067",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 67.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 67.",
    clinical_significance="Standard therapeutic monitoring parameter 67.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_068"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_068",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200068",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 68.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 68.",
    clinical_significance="Standard therapeutic monitoring parameter 68.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_069"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_069",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200069",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 69.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 69.",
    clinical_significance="Standard therapeutic monitoring parameter 69.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_070"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_070",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200070",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 70.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 70.",
    clinical_significance="Standard therapeutic monitoring parameter 70.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_071"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_071",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200071",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 71.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 71.",
    clinical_significance="Standard therapeutic monitoring parameter 71.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_072"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_072",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200072",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 72.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 72.",
    clinical_significance="Standard therapeutic monitoring parameter 72.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_073"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_073",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200073",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 73.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 73.",
    clinical_significance="Standard therapeutic monitoring parameter 73.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_074"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_074",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200074",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 74.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 74.",
    clinical_significance="Standard therapeutic monitoring parameter 74.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_075"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_075",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200075",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 75.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 75.",
    clinical_significance="Standard therapeutic monitoring parameter 75.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_076"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_076",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200076",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 76.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 76.",
    clinical_significance="Standard therapeutic monitoring parameter 76.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_077"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_077",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200077",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 77.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 77.",
    clinical_significance="Standard therapeutic monitoring parameter 77.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_078"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_078",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200078",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 78.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 78.",
    clinical_significance="Standard therapeutic monitoring parameter 78.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_079"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_079",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200079",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 79.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 79.",
    clinical_significance="Standard therapeutic monitoring parameter 79.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_080"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_080",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200080",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 80.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 80.",
    clinical_significance="Standard therapeutic monitoring parameter 80.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_081"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_081",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200081",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 81.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 81.",
    clinical_significance="Standard therapeutic monitoring parameter 81.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_082"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_082",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200082",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 82.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 82.",
    clinical_significance="Standard therapeutic monitoring parameter 82.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_083"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_083",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200083",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 83.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 83.",
    clinical_significance="Standard therapeutic monitoring parameter 83.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_084"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_084",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200084",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 84.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 84.",
    clinical_significance="Standard therapeutic monitoring parameter 84.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_085"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_085",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200085",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 85.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 85.",
    clinical_significance="Standard therapeutic monitoring parameter 85.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_086"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_086",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200086",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 86.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 86.",
    clinical_significance="Standard therapeutic monitoring parameter 86.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_087"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_087",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200087",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 87.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 87.",
    clinical_significance="Standard therapeutic monitoring parameter 87.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_088"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_088",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200088",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 88.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 88.",
    clinical_significance="Standard therapeutic monitoring parameter 88.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_089"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_089",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200089",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 89.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 89.",
    clinical_significance="Standard therapeutic monitoring parameter 89.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_090"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_090",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200090",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 90.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 90.",
    clinical_significance="Standard therapeutic monitoring parameter 90.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_091"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_091",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200091",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 91.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 91.",
    clinical_significance="Standard therapeutic monitoring parameter 91.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_092"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_092",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200092",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 92.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 92.",
    clinical_significance="Standard therapeutic monitoring parameter 92.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_093"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_093",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200093",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 93.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 93.",
    clinical_significance="Standard therapeutic monitoring parameter 93.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_094"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_094",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200094",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 94.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 94.",
    clinical_significance="Standard therapeutic monitoring parameter 94.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_095"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_095",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200095",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 95.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 95.",
    clinical_significance="Standard therapeutic monitoring parameter 95.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_096"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_096",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200096",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 96.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 96.",
    clinical_significance="Standard therapeutic monitoring parameter 96.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_097"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_097",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200097",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 97.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 97.",
    clinical_significance="Standard therapeutic monitoring parameter 97.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_098"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_098",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200098",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 98.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 98.",
    clinical_significance="Standard therapeutic monitoring parameter 98.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_099"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_099",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200099",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 99.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 99.",
    clinical_significance="Standard therapeutic monitoring parameter 99.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_100"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_100",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200100",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 100.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 100.",
    clinical_significance="Standard therapeutic monitoring parameter 100.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_101"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_101",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200101",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 101.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 101.",
    clinical_significance="Standard therapeutic monitoring parameter 101.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_102"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_102",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200102",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 102.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 102.",
    clinical_significance="Standard therapeutic monitoring parameter 102.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_103"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_103",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200103",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 103.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 103.",
    clinical_significance="Standard therapeutic monitoring parameter 103.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_104"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_104",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200104",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 104.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 104.",
    clinical_significance="Standard therapeutic monitoring parameter 104.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_105"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_105",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200105",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 105.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 105.",
    clinical_significance="Standard therapeutic monitoring parameter 105.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_106"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_106",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200106",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 106.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 106.",
    clinical_significance="Standard therapeutic monitoring parameter 106.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_107"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_107",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200107",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 107.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 107.",
    clinical_significance="Standard therapeutic monitoring parameter 107.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_108"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_108",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200108",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 108.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 108.",
    clinical_significance="Standard therapeutic monitoring parameter 108.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_109"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_109",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200109",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 109.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 109.",
    clinical_significance="Standard therapeutic monitoring parameter 109.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_110"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_110",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200110",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 110.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 110.",
    clinical_significance="Standard therapeutic monitoring parameter 110.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_111"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_111",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200111",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 111.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 111.",
    clinical_significance="Standard therapeutic monitoring parameter 111.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_112"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_112",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200112",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 112.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 112.",
    clinical_significance="Standard therapeutic monitoring parameter 112.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_113"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_113",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200113",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 113.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 113.",
    clinical_significance="Standard therapeutic monitoring parameter 113.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_114"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_114",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200114",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 114.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 114.",
    clinical_significance="Standard therapeutic monitoring parameter 114.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_115"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_115",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200115",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 115.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 115.",
    clinical_significance="Standard therapeutic monitoring parameter 115.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_116"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_116",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200116",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 116.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 116.",
    clinical_significance="Standard therapeutic monitoring parameter 116.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_117"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_117",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200117",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 117.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 117.",
    clinical_significance="Standard therapeutic monitoring parameter 117.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_118"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_118",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200118",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 118.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 118.",
    clinical_significance="Standard therapeutic monitoring parameter 118.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_119"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_119",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200119",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 119.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 119.",
    clinical_significance="Standard therapeutic monitoring parameter 119.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_120"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_120",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200120",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 120.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 120.",
    clinical_significance="Standard therapeutic monitoring parameter 120.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_121"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_121",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200121",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 121.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 121.",
    clinical_significance="Standard therapeutic monitoring parameter 121.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_122"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_122",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200122",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 122.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 122.",
    clinical_significance="Standard therapeutic monitoring parameter 122.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_123"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_123",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200123",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 123.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 123.",
    clinical_significance="Standard therapeutic monitoring parameter 123.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_124"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_124",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200124",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 124.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 124.",
    clinical_significance="Standard therapeutic monitoring parameter 124.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_125"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_125",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200125",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 125.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 125.",
    clinical_significance="Standard therapeutic monitoring parameter 125.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_126"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_126",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200126",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 126.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 126.",
    clinical_significance="Standard therapeutic monitoring parameter 126.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_127"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_127",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200127",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 127.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 127.",
    clinical_significance="Standard therapeutic monitoring parameter 127.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_128"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_128",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200128",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 128.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 128.",
    clinical_significance="Standard therapeutic monitoring parameter 128.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_129"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_129",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200129",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 129.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 129.",
    clinical_significance="Standard therapeutic monitoring parameter 129.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_130"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_130",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200130",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 130.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 130.",
    clinical_significance="Standard therapeutic monitoring parameter 130.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_131"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_131",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200131",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 131.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 131.",
    clinical_significance="Standard therapeutic monitoring parameter 131.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_132"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_132",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200132",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 132.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 132.",
    clinical_significance="Standard therapeutic monitoring parameter 132.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_133"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_133",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200133",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 133.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 133.",
    clinical_significance="Standard therapeutic monitoring parameter 133.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_134"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_134",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200134",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 134.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 134.",
    clinical_significance="Standard therapeutic monitoring parameter 134.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_135"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_135",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200135",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 135.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 135.",
    clinical_significance="Standard therapeutic monitoring parameter 135.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_136"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_136",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200136",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 136.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 136.",
    clinical_significance="Standard therapeutic monitoring parameter 136.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_137"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_137",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200137",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 137.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 137.",
    clinical_significance="Standard therapeutic monitoring parameter 137.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_138"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_138",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200138",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 138.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 138.",
    clinical_significance="Standard therapeutic monitoring parameter 138.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_139"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_139",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200139",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 139.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 139.",
    clinical_significance="Standard therapeutic monitoring parameter 139.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_140"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_140",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200140",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 140.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 140.",
    clinical_significance="Standard therapeutic monitoring parameter 140.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_141"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_141",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200141",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 141.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 141.",
    clinical_significance="Standard therapeutic monitoring parameter 141.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_142"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_142",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200142",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 142.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 142.",
    clinical_significance="Standard therapeutic monitoring parameter 142.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_143"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_143",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200143",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 143.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 143.",
    clinical_significance="Standard therapeutic monitoring parameter 143.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_144"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_144",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200144",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 144.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 144.",
    clinical_significance="Standard therapeutic monitoring parameter 144.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_145"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_145",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200145",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 145.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 145.",
    clinical_significance="Standard therapeutic monitoring parameter 145.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_146"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_146",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200146",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 146.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 146.",
    clinical_significance="Standard therapeutic monitoring parameter 146.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_147"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_147",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200147",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 147.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 147.",
    clinical_significance="Standard therapeutic monitoring parameter 147.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_148"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_148",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200148",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 148.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 148.",
    clinical_significance="Standard therapeutic monitoring parameter 148.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_149"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_149",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200149",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 149.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 149.",
    clinical_significance="Standard therapeutic monitoring parameter 149.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=False
)

DRUG_INTERACTIONS_REGISTRY["PHARMACEUTICAL_AGENT_150"] = DrugLabInteraction(
    drug_name="Pharmaceutical_Agent_150",
    drug_class=DrugClass.ANTIHYPERTENSIVES if i % 2 == 0 else DrugClass.ANTIDIABETICS,
    rxnorm_code="200150",
    affected_biomarkers=["GLUCOSE_FASTING", "CREATININE", "ALT", "POTASSIUM"],
    expected_alteration="Modulates cellular biochemical pathways with predictable biomarker shifts for agent 150.",
    mechanism="Receptor modulation and enzymatic pathway regulation index 150.",
    clinical_significance="Standard therapeutic monitoring parameter 150.",
    recommended_monitoring="Periodic clinical laboratory review every 3 to 6 months.",
    artifact_risk=True
)

def get_drug_interactions(drug_name: str) -> Optional[DrugLabInteraction]:
    return DRUG_INTERACTIONS_REGISTRY.get(drug_name.strip().upper())

def find_drugs_affecting_biomarker(biomarker_code: str) -> List[DrugLabInteraction]:
    b_code = biomarker_code.strip().upper()
    return [d for d in DRUG_INTERACTIONS_REGISTRY.values() if b_code in d.affected_biomarkers]

def evaluate_medication_list(medications: List[str], abnormal_biomarkers: List[str]) -> List[Dict[str, Any]]:
    results = []
    for med in medications:
        record = get_drug_interactions(med)
        if record:
            overlapping = [b for b in abnormal_biomarkers if b.upper() in record.affected_biomarkers]
            if overlapping:
                results.append({
                    "drug_name": record.drug_name,
                    "drug_class": record.drug_class.value,
                    "impacted_biomarkers": overlapping,
                    "expected_alteration": record.expected_alteration,
                    "clinical_significance": record.clinical_significance,
                    "monitoring": record.recommended_monitoring
                })
    return results
